PERBANDINGAN CD4 HIV –TB PARU SEBELUM DAN SESUDAH ARV DAN OAT

Trivania Cesia; Pantas Hasibuan; Johan Christian Silaen

doi:10.51622/eksakta.v5i1.2484

Authors

Trivania Cesia universitas hkbp nommensen medan
Pantas Hasibuan universitas hkbp nommensen medan
Johan Christian Silaen universitas hkbp nommensen medan

DOI:

https://doi.org/10.51622/eksakta.v5i1.2484

Abstract

Background: Human Immunodeficiency Virus (HIV) is a viral infectious disease that attacks the immune system or white blood cells (lymphocytes). HIV, which belongs to the Retroviridae family, is lymphatic, which can damage the specific immune system, namely T-helper lymphocytes or Cluster of Differentiation 4 (CD4). The CD4 count is normal when it is 500–1400 cells/mm³, which is usually the determinant of whether a patient is infected with HIV or not.

Objective: This study aims to assess the comparison of CD4 counts in HIV-TB patients before and after ARV and OAT treatment at Dr. Pirngadi Medan City.

Methods: Observational analysis research with a cross-sectional design was conducted at RSUD Dr. Pirngadi Medan City in September 2022. The sample for this study was 20 patient records from the medical records of RSUD Dr. Pirngadi, Medan City. The data were analyzed using an unpaired t-test.

Results: The results of the study showed that the most HIV-TB pulmonary patients at RSUD Dr. Pirngadi Medan City were aged 36-45 years (50.0%). The majority of male patients (90.0%) and the domicile of most patients in Medan City are in the Medan Tembung sub-district (15.0%). The results of the unpaired t-test obtained a p-value of 0.022, meaning that there was a significant difference between the CD4 count before and after ARV and OAT treatment in HIV-TB patients at RSUD Dr. Pirngadi Medan City.

Conclusion: There were significant differences in CD4 counts before and after ARV and OAT treatment in HIV patients with pulmonary TB co-infection at Dr. Pirngadi, Medan City.

Keywords: HIV, HIV-TB pulmonary, CD4

Downloads

Download data is not yet available.

References

Djoerban Z, Djauzi S. HIV/AIDS DI INDONESIA. In: Setiati S, Alwi I, Sudoyo AW, K. MS, Setiyohadi B, Syam AF, editors. Ilmu Penyakit Dalam. 6th ed. Jakarta: InternaPublishing; 2014. p. 887–97.

Baratawidjaja KG, Rengganis I. Imunologi Dasar. 10th ed. Jakarta: Badan Penerbit Fakultas Kedokteran Universitas Indonesia; 2019.

Kemenkes RI. Pedoman Interpretasi Data Klinik. Kementrian Kesehat RI. 2020;(January):66–7.

Li R, Duffee D, Gbadamosi-Akindele MF. CD4 Count. StatPearls. 2022. Diakses melalui: https://www.ncbi.nlm.nih.gov/books/NBK470231/

UNAIDS. Global HIV & AIDS statistics. UNAIDS. 2021. Diakses melalui: https://www.unaids.org/en/resources/fact-sheet

WHO. HIV/AIDS. Word Health Organization Genevac. 2021. Diakses melalui: https://www.who.int/news-room/fact-sheets/detail/hiv-aids

Sumut D. Profil Kesehatan Provinsi Sumatera Utara. Vol. III, Dinas Kesehatan Provinsi Sumatera Utara. Sumatera Utara: Dinas Kesehatan; 2019. 68–80 p.

Burhan E, Soeroto AY, Isbaniah F. Pedoman Nasional Pelayanan Kedokteran Tata Laksana Tuberkulosis. Sastroasmoro S, editor. Kementrian Kesehatan Republik Indonesia. Jakarta; 2020. 54–57 p.

Yogani I, Karyadi TH, Uyainah A, Koesnoe S. Faktor-faktor yang berhubungan dengan kenaikan CD4 pada pasien HIV yang mendapat highly active antiretroviral therapy dalam 6 bulan pertama. J Penyakit Dalam Indones. 2017;2(4):217.

Siahaan DN, Safitri D, Silalahi N, Gunawan M. Evaluasi perpaduan obat ARV pada pasien HIV/AIDS ditinjau dari kenaikan jumlah limfosit CD4 di RSUP H. Adam Malik tahun 2016. J Stikna. 2018;02(October):1–6.

Aulia A, Rahayu SR, Fauzi L, Prameswari GN. Determinan perubahan kadar CD4 pada orang dengan HIV/AIDS koinfeksi TB. Indones J Public Heal Nutr. 2021;1(1):472–8.

Amalia NR, Utama IMS. Korelasi hasil basil tahan asam dengan kadar CD4 pada pasien koinfeksi HIV-TB di RSUP Sanglah Denpasar. J Med Udaya. 2020;9(9):100–4.

Permatasari J, Meirista I, Bafadhal H. Hubungan kombinasi antiretroviral terhadap kadar CD4 pasien HIV TB rawat jalan RSUD H.Abdul Manap Jambi. J Pharm Sci. 2021;6(2):75–9.

Fitriana E, Camin YR, Widowati R. Hubungan obata anti tuberkulosis dengan jumlah CD4 pasien koinfeksi Tb-HIV di RSUD Jayapura Papua. Plasma. 2014;1.

Adiningsih S, Widiyanti M, Natalia EI, Wahyuni T. CD4+ dan Faktor yang Memengaruhi Kepatuhan Terapi Antiretroviral pada Orang dengan HIV/AIDS di Jayapura. Bul Penelit Kesehat. 2018;46(2):87–96.

Anggraini AS. Literature Review : Faktor-Faktor Yang Mempengaruhi Peningkatan Kadar Cd4 Pada Pasien Hiv Yang Mendapat Highly Active Antiretroviral Therapy ( Haart ) Halaman Persetujuan Literature Review : Faktor-Faktor Yang Mempengaruhi Peningkatan Kadar Cd4 Pada Pasie. Universitas ‘Aisyiyah; 2021.